🇺🇸 FDA

Intelligence Platform

Patents

Browse 23 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12364745

Immunogenicity of a CpG-adjuvanted recombinant plague vaccine

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12292441

Recombinant Acinetobacter baumannii strain AB5075

The Government of the United States, as represented by the Secretary of the Army · Granted Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11963959

Inhibitors for coronavirus

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11884718

Potent zika virus-specific and cross-neutralizing monoclonal antibodies to zika and dengue

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11865111

Antiviral drugs targeting the N-terminal domain (NTD) of the coronavirus spike receptor bi

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11744828

Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11691992

Oxaborole analogs and uses thereof

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11583578

Plasmodium falciparum recombinanr xiexumapoeozoite protein compositions and method for vac

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11459308

Broad spectrum inhibitors of filoviruses

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11440951

Therapeutic antibodies to Marburg virus

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Sep 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11389400

Aerosilization of stem cells or stem cell derivatives for pulmonary delivery

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11345653

Compositions and methods for reactivating cholinesterases

The Government of the United States, as represented by the Secretary of the Army · Granted Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11155834

Sin Nombre virus full-length M segment-based DNA vaccines

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11053285

Nucleic acids encoding human immunodeficiency virus type 1 (HIV-1) N-terminal deleted gp12

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11033615

Zika virus vaccine and methods of production

The Government of the United States, As Represented by the Secretary of the Army Fort Detrick, Maryland · Granted Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11013791

NYVAC-based plasmodium malaria vaccine

The Government of the United States, as represented by the Secretary of the Army · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10888558

Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10875907

Filovirus antibody

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10548946

Therapeutic compositions for neutralizing type I interferons, and methods of use

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10525123

Methods for inducing an immune response against human immunodeficiency virus infection in

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10443073

Sin Nombre virus full-length M segment-based DNA vaccines

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10435461

Therapy for filovirus infection

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10434167

Non-toxic adjuvant formulation comprising a monophosphoryl lipid A (MPLA)-containing lipos

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted